PT Champ Resto Indonesia Tbk (IDX:ENAK)

Orchard Therapeutics Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	38,492	41,351	48,816	63,414	57,983	59,768
Cash & Short-Term Investments	38,492	41,351	48,816	63,414	57,983	59,768
Cash Growth	-22.91%	-15.29%	-23.02%	9.37%	-2.99%	-11.88%
Accounts Receivable	9,690	5,989	8,379	9,672	4,788	3,250
Other Receivables	5,844	3,868	3,153	13,798	5,091	3,287
Receivables	15,534	9,857	11,533	23,470	9,879	6,537
Inventory	39,397	41,641	40,269	31,219	29,056	16,788
Prepaid Expenses	22,406	20,668	21,806	15,302	8,124	5,496
Other Current Assets	14,486	15,590	25,691	16,020	10,383	19,095
Total Current Assets	130,315	129,108	148,115	149,425	115,425	107,685
Property, Plant & Equipment	888,523	863,297	809,402	566,733	457,237	482,578
Other Intangible Assets	10,207	11,411	17,504	23,774	30,043	36,333
Long-Term Deferred Tax Assets	21,025	21,132	21,649	21,948	19,850	11,005
Other Long-Term Assets	59,655	58,107	54,278	46,036	37,699	34,576
Total Assets	1,116,412	1,090,107	1,059,299	817,515	671,155	672,176
Accounts Payable	69,998	64,648	87,718	83,842	48,100	21,697
Accrued Expenses	82,360	75,006	79,752	45,766	74,205	91,746
Short-Term Debt	26,422	25,950	26,219	19,692	50,602	24,144
Current Portion of Long-Term Debt	68,519	62,124	75,112	32,226	34,782	21,362
Current Portion of Leases	143,069	128,146	121,966	85,544	90,813	82,923
Current Income Taxes Payable	6,116	6,028	5,099	3,309	5,087	-
Current Unearned Revenue	2,007	2,683	1,842	1,354	772.97	733.26
Other Current Liabilities	40,017	37,898	33,208	5,714	4,314	6,313
Total Current Liabilities	438,507	402,483	430,916	277,448	308,677	248,919
Long-Term Debt	153,572	150,828	116,916	78,944	103,198	108,417
Long-Term Leases	234,715	236,711	230,893	138,450	119,205	115,122
Other Long-Term Liabilities	-	-	-	39,415	59,980	77,117
Total Liabilities	843,752	806,471	794,968	548,781	606,316	561,801
Common Stock	21,667	21,667	21,667	21,667	20,000	20,000
Additional Paid-In Capital	170,382	170,382	170,382	170,382	32,067	32,067
Retained Earnings	79,499	90,475	72,623	77,272	14,987	22,314
Comprehensive Income & Other	1,112	1,112	-341.35	-586.61	-2,215	35,994
Shareholders' Equity	272,660	283,636	264,331	268,734	64,839	110,375
Total Liabilities & Equity	1,116,412	1,090,107	1,059,299	817,515	671,155	672,176
Total Debt	626,298	603,760	571,106	354,856	398,600	351,968
Net Cash (Debt)	-587,805	-562,409	-522,290	-291,442	-340,617	-292,199
Net Cash Per Share	-271.29	-259.57	-241.06	-134.51	-170.31	-146.10
Filing Date Shares Outstanding	2,167	2,167	2,167	2,167	2,000	2,000
Total Common Shares Outstanding	2,167	2,167	2,167	2,167	2,000	2,000
Working Capital	-308,193	-273,375	-282,801	-128,022	-193,252	-141,234
Book Value Per Share	125.84	130.91	122.00	124.03	32.42	55.19
Tangible Book Value	262,454	272,225	246,828	244,961	34,796	74,042
Tangible Book Value Per Share	121.13	125.64	113.92	113.06	17.40	37.02
Land	46,607	46,607	46,607	46,607	46,607	46,607
Buildings	33,626	33,626	32,281	32,248	32,025	32,025
Machinery	294,729	286,529	255,581	202,058	155,646	142,307
Construction In Progress	28,024	28,815	10,899	25,895	18,168	15,404

Source: S&P Global Market Intelligence. Standard template. Financial Sources.